• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD BIOSCIENCES BD FACSCANTO SYSTEM II UPGRADE V2.4; BD FACSCANTO CLINICAL SOFTWARE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD BIOSCIENCES BD FACSCANTO SYSTEM II UPGRADE V2.4; BD FACSCANTO CLINICAL SOFTWARE Back to Search Results
Catalog Number 646603
Device Problems False Positive Result (1227); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Misdiagnosis (2159)
Event Date 12/01/2014
Event Type  malfunction  
Event Description
The incident occurred at the (b)(6) bd biosciences facscanto clinical software complaint (b)(4).A (b)(6) pt received a t-cell depleted hsct and engrafted with a very low t cell count.During follow up a sample (unclear whether marrow aspirate or pb) was gated automatically by the canto clinical software such that a very high level of t cell positivity was demonstrated.This turned out to be an incorrect result as the pt continued to have less than 1% t cells.Upon review, a very small cd 3+ subset was seen; however, the software algorithm did not recognize this small population as cd3+.Instead, it mistakenly drew the gate in the middle of a cd3- population resulting in a falsely elevated cd3+ population.According to dr (b)(6), the attending md for the flow lab, there was no adverse clinical impact to the pt as a consequence of this erroneous result.The incorrect result was manually re-gated in diva to reveal the continued presence of t-cell lymphopenia.Specifically, on (b)(6) 2014 and again on (b)(6) 2014, the bd facscanto clinical software categorized most cd3 lymphocyte population as positive on the pt samples.The result did not match pt medical history.After manual adjustment, the cd3% changed from 92.91% to 0.66%.The negative cd3% was confirmed by using bd facs diva software.
 
Manufacturer Narrative
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACSCANTO SYSTEM II UPGRADE V2.4
Type of Device
BD FACSCANTO CLINICAL SOFTWARE
Manufacturer (Section D)
BD BIOSCIENCES
2350 qume dr.
san jose CA 95131
Manufacturer Contact
eric claussen
2350 qume dr.
san jose, CA 95131
4089546348
MDR Report Key4577220
MDR Text Key5486291
Report Number2916837-2015-00001
Device Sequence Number1
Product Code GKZ
Combination Product (y/n)N
PMA/PMN Number
K062087
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Remedial Action Recall
Type of Report Initial
Report Date 02/23/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number646603
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/16/2014
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-